• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Graphite backs management buyout of Hanson Wade

  • Kenny Wastell
  • Kenny Wastell
  • @kennywastell
  • 15 August 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Graphite Capital has supported the management buyout of Hanson Wade, a UK-headquartered event production company and data provider.

Financial details of the transaction remain undisclosed, though a report by Unquote sister publication Mergermarket cited sources who said the deal values Hanson Wade at £96m and was based on EBITDA of £8m.

The company's founder, Sarah McCaldin, has reinvested for a minority stake in the business and will remain with Hanson Wade in the role of non-executive director.

Hanson Wade

  • DEAL:

    MBO

  • VALUE:

    n/d (£96m est)

  • LOCATION:

    London

  • SECTOR:

    Media agencies

  • FOUNDED:

    2008

  • TURNOVER:

    £22.6m (2018)

  • EBITDA:

    n/d (£8m est)

Graphite is currently investing from Graphite Capital Partners IX, which held a final close on £470m in July last year. It plans to make 8-12 deals. The vehicle focuses on UK mid-market companies with enterprise values of £30-150m.

Hanson Wade intends to pursue bolt-on opportunities, in addition to capitalising on growing global demand for corporate events and conferences. The company's revenues increased by 117% to £22.6m between 2016 and 2018, according to a statement, with its number of events almost doubling during the same period.

Crescent Capital Group and HSBC provided a debt package to support the transaction.

Company
Founded in 2008, London-headquartered Hanson Wade is an event and conference production company focusing primarily on the pharmaceutical and biotechnology sectors. Its Beacon product provides customers with access to data and research related to clinical trials and niche bio-pharma segments. It also produces events related to human resources, construction and engineering. The majority of the company's revenues are generated from US sales.

People
Graphite Capital – Humphrey Baker (partner); Mike Tilbury (head of new investment); Tony Saade (investment director); Liam McGivern (partner).
Hanson Wade – Tom Richardson (CEO).

Advisers
Equity – PwC, Malcolm Wren, Graeme Scott, Jonathan Cooper, Tom Williams (corporate finance, financial due diligence); Goodwin Procter, Richard Lever, Simon Fulbrook, Stan Shishkin (legal); Clearwater International, Chris Smith, Lachlan Dorrity (debt advisory); CIL, Tabitha Elwes, Luke Rowell (commercial due diligence).
Vendor – Cardean Bell, Peter Bell, Oliver Levy (corporate finance); Macfarlanes, Jessica Adam, Mark Stephens (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • UK / Ireland
  • Media
  • United Kingdom
  • Graphite Capital
  • PwC
  • Goodwin
  • Clearwater

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013